Phase I trial of dacomitinib, a pan-human epidermal growth...

Investigational New Drugs 2016 / 10 Vol. 34; Iss. 5

Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001)

Prawira, Amy, Brana-Garcia, Irene, Spreafico, Anna, Hope, Andrew, Waldron, John, Razak, Albiruni R. Abdul, Chen, Eric X, Jang, Raymond, O’Sullivan, Brian, Giuliani, Meredith, Bayley, Andrew, Cho, John
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
34
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-016-0367-2
Date:
October, 2016
File:
PDF, 415 KB
english, 2016
Conversion to is in progress
Conversion to is failed